## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 



## 



## 



## 

## 



## 

## 

## 

## 



||||||||4 O <br>O0 <br>'cl<br>Dl|4 O <br>O0 <br>'cl<br>Dl|O Dl O<br> CV 0) (D<br> CI~ (O|'Ig<br>CO<br>CO LA <br>00 W|'Cl<br>CD<br> Cg O<br> (I)~|'Cl<br>CD<br> Cg O<br> (I)~|IA<br>CD<br>CO|IA<br>CIL|CI<br>CII<br>Ol||IA<br>CO|LA<br>40|||LA Cg<br>F) LA|CO<br>Cl||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||'0||||LA|~|O 40 O|CII F<br>0 (4<br>CII|CLI||Ol<br>(D||CD<br>CD||Q(0<br>CI)|CI<br>CD|||CD O<br>C0 IA|Q<br>CD||||
||||N<br>Q<br>V 'U<br>'I<br>C (II<br>Q<br>N LL<br>IL||||LA <br>N <br>CII|O<br> O<br> Ol|I<br>CO<br>I<br>Q<br>Cg|I<br>(0<br>IA|I|I|Q<br>IA(0|I|Q<br>IA<br>(O|||CO<br>CII<br>(O|P) <br>40 <br>IA|(0<br> CO|4 CII<br>Dl<br>CO|||||
||O<br>CV<br>V<br>L<br>lgZ|'U<br>Q<br>VC<br>NQ<br>CD|'U<br>Ul<br>Q<br>C &<br>D'<br>CV<br>~-m0<br>N I- LL<br>Q I-<br>O||||IA<br>Cg<br>CD|I|I<br>(I) (O<br>'Ig' (O|CV (O <br>'II'<br>CO<br>CD CD <br>(I) F) <br>O I-|'Ct <br>CV <br> (I)<br> P)<br> CIL|(I)<br> IA|LA<br>(O<br>CO<br>CD|Cg|||COQ<br>00|COQ<br>CO|LA <br>LA <br>CO|CII<br> (0<br>~|Gl (I)<br>(I)r<br>W CD<br>(I) IA|(0<br>CII<br>IA<br>(I)<br>Dl||||
||'U<br>Cl<br>'U<br>C<br>Cl<br>lg<br>Cl<br>Q|'U<br>Q<br>V<br>I<br>NQc<br>D|'U<br>Q<br>(4 Ig,''U<br>Ul+ 0'II<br>CI<br>'N —LL<br>Cl<br>Ci||||CO<br>CO<br>CV||OOO<br>CII0 O<br>QOQ<br>Q IA (I)|IA CII<br>W (I)<br>00~||LA|||||(0I|IA<br>P)<br>(O|(0 <br>0 <br>Q<br>(V|CII<br> (Il|CD W<br>(I) (Il<br>CD<br>Gl (D<br>~ IA|||||
||I0|||||||||||||||||||||||||
||~I|||||||||||||||||||||||||
||c|||||||||||||||||||||||||
||0V|||||||||||||||||||||||||
|Q<br>N<br>V<br>N<br>Cl<br>E0<br>O<br>0|Cl<br>'ULQG.<br>LLI<br>'U<br>L<br>m||'U<br>N<br>Q<br>V 'U<br>C M<br>Q<br>N LL||||OQQ<br>LA<br>QQ<br>IA<br>CII||4 O<br>F) O<br>(Il O<br>F) CO<br>IA<br>I (4<br>CO<br>CI|IA<br>CIL <br>(O CD <br>O 'II' <br>~ CI <br>CO CV <br>CO<br>I<br>CD<br>CD<br>IA|CD <br>0<br> N <br> (I) <br> LA<br>I|Q<br>0<br> O<br> IA<br>I|0O<br>(0<br>(O<br>(O<br>CII<br>CD<br>CV<br>Clo|CO<br>(I)|Cg<br>(D<br>Cg<br>Clo|||(D<br>CD<br>IA<br>CII<br>CD|Cl<br>CIL<br>CO||O<br>CO<br>Cg O<br>N O<br>00 (D<br>(O IA<br>(O CO<br>CD 00<br>CO (0|CI<br>Dl<br>CIL<br>CII<br>IA<br>CO<br>IA||||
|gl<br>IL<br>Q<br>CDc<br>V<br>'U<br>Q<br>IL|E0V<br>C<br>IU<br>Ulc<br>0.<br>I0VC<br>NQ<br>(U<br>VC<br>ClL|'U<br>Q<br>VC<br>NQ<br>CD<br>'U<br>Q<br>V<br>NQ<br>D<br>Q02|'U<br>Q<br>CD<br>m,c 0<br>P-„0~<br>c<br>c<br>~—m LL<br>Q I-<br>Ci<br>'U<br>Qm+'U<br>ml+<br>Z (II<br>.—O<br>'N —LL<br>ClO||||Q<br>IA<br>CV|I|I Q<br>CIQ<br>T<br>QQO<br>CII<br>I<br>IA<br>CO<br>CI<br>Q<br>CIo<br>(O|(V<br>'<br>Cg<br>(0<br>(0<br>LA Cg<br>P<br>CD<br>CO O<br>CD 04|CD<br>O<br>(9<br>LA|O<br>CIQ<br>LA|CI)<br>CII<br>(O<br>(I)<br>O<br>Q<br>CII|CO|(O<br>CI<br>CV||(O<br>Q<br>(I)<br>Dl|(D<br>'4'<br>CD<br>CD<br>Q<br>CD|IA<br>COQ<br>CV<br>IA <br>Cg <br>'IL|W<br> 4<br>CV|IA (0<br>CO CII<br>O LA<br>CII (I)<br>W Dl<br>CV CD<br>IA h<br>~ (D<br>(O Ol|(0<br>IA<br>(Il<br>CO<br>CII<br>00<br>IA|Cl<br>gl<br>e<br>L<br>ClN<br>Ul0V<br>gl<br>N<br>ClN<br>M0 aj<br>gl<br>Lm.~<br>(I) '6<br>(4<br>(U<br>Ul<br>Ul C<br>m c||8<br>4l<br>E<br>Q<br>(4<br>m<br>Vc<br>mC<br>(C<br>Q<br>NQ|
||LL<br>0<br>C<br>Cl<br>E<br>Cl<br>Co||Z|'0L<br>gl<br>I<br>Cl<br>e E<br>e<br>IU<br>8 0<br> C)||(U|QL0<br>E<br>E<br>O<br>glE<br>IO e<br>m0<br>gl<br>Q<br>o E<br>0 0<br>Q.Z<br>VC<br>0O<br>0O<br>4l<br>Zo<br>N<br>.0<br>(U<br>N 0<br>AO<br>0<br>E (4<br>IIL<br>(U ~<br>eI-<br>(U<br>(U<br>O|||e<br>0<br>NU<br>W<br>O<br>gl<br>N<br>~OC(4<br>0<br>Cg .<br>'C<br>(4 V<br>co'DE<br>O CI<br>LU 0<br>CD V<br>gl<br>I 0|||0C<br>(U<br>0V<br>gl<br>CO<br>0~<br>ClCm<br>m<br>gl<br>(U<br>(4~||0<br>O2<br>I-0I-|D<br>2 <br>O.X <br>LLI|V<br>4l<br>Xl<br>(U<br>I<br>(U<br>O<br>L<br>gl<br>I<br> '0<br>C<br> l(<br>LLI|ILI<br>DI-02<br>LLI<br>D.X<br>III<br>I-0I-|ClL<br>N0<br>~<br>C<br>Q L<br>0.e<br>.C L<br>(4<br>Z I-||gl<br>'U<br>U<br>CIL<br>II 0<br>C<br>CIL<br>0.<br>Q C(<br>Q ~<br>&<br>m<br>ON<br>EuC<br>Q2 LL|CIL<br>CILO<br>V<br>N'0<br>C<br>LL|fh ~<br>e C00<br>v E<br>P<br>u& ~<br>gl<br>gl<br>I<br>Cl<br>O U<br>m<br>gl<br>(4<br>m C<br>c e<br>el(<br>Ce<br>m<br>E<br>Cl<br>gl<br>m<br>gl—<br>I—&||0<br>gl0.<br>E<br>CO<br>0<br>CU<br>N4l<br>Ul<br>m0.<br>C0<br>NQ0C<br>Q<br>I-|





||||Reduc|ing the Risk ofDomestic Abuse|ing the Risk ofDomestic Abuse|||
|---|---|---|---|---|---|---|---|
|||||Balance Sheet||||
|||||as at 31 March 2022||||
|||||Note|2022|2021||
|Fixed assets||||||||
|Tangible assets|||||1,188||1,486|
|Current assets||||||||
|Debtors|||||129,327|23,872||
|Bank current account|||||48,782|244,858||
|Bank deposit account|||||152,384|||
|Total current assets|||||330,493|268,730||
|Creditors: amounts|falling due|||||||
|within one year|||||(54,391)|(80,129)||
|Net current assets|||||276,102||188,601|
|Net assets|||||277,290||190,087|
|Funds||||||||
|Unrestricted<br>designated||IDVA fund||10|115,828||79,676|
|Unrestricted<br>designated||Training|fund|10|135,611||93,526|
|Restricted funds||||10|25,851||16,885|
||||||277,290||190,087|







## 

## 



## 

## 

## 

## 

|Charitable<br>expen|diture||||2022|
|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|
|Office rent|||8,200|2,610|10,810|
|Wages 8 salaries|incl Nl and pension scheme||244,072|50,785|294,857|
|Associate trainers|||9,966||9,966|
|Printing,<br>IT, phone|and office costs||2,253|933|3,186|
|Recruitment|||23|546|569|
|Travel and service|expenses||8,384|4,204|12,588|
|Training team|||9,267||9,267|
|Service user support||||1,377|1,377|
|Group Support||||23,437|23,437|
|Clinical Support|||2,137||2,137|
|Website/communication<br>service, champion||support|74|7,924|7,998|
|Insurance|||451|130|581|
|Governance<br>costs|||2,057|653|2,710|
|Depreciation|||298||298|
||||287,182|92,599|379,781|
||||||2021|
||||Unrestricted|Restricted|Total|
|Office rent|||12,278||12,278|
|Wages 8 salaries|incl NI and pension scheme||270,763|22,524|293,287|
|Associate trainers||||13,862|13,862|
|Printing,<br>IT, phone|and office costs||1,222||1,222|
|Additional<br>COVID|expenses|||2,886|2,886|
|Travel and service|expenses||3,792|1,163|4,955|
|Training team|||2,912||2,912|
|Service user support|||1,036||1,036|
|Group Support||||1,815|1,815|
|Clinical Support|||1,704||1,704|
|Website/communication<br>service, champion||support||11,490|11,490|
|MODUS restricted|project|||9,000|9,000|
|Insurance|||826|93|919|
|Governance<br>costs|||2,521||2,521|
|Depreciation|||298||298|
||||297,352|62,833|360,185|





## 

## 

## 

## 

## 

|Net movement<br>in funds||||||
|---|---|---|---|---|---|
|||||2022|2021|
|||||E||
|This is stated after charging:||||||
|Independent<br>examiner's|fees|||2,058|1,965|
|Staff costs and numbers||||||
|||||2022|2021|
|||||E|E|
|Salaries and wages - gross||||265,434|267,816|
|Social security costs||||25,145|21,074|
|Pension costs||||4,278|4,397|
|||||294,857|293,287|
|The average weekly number ofemployees||(full-time|equivalent)|during the year was as follows:||
|Direct charitable<br>activities|||||10|



## 

## 

## 

## 

|Tangible fixed assets||
|---|---|
||Office|
||Equipment|
|Cost||
|At 1 April 2021 and at 31 March 2022|3,847|
|Depreciation||
|At 1stApril 2021|2,361|
|Charge for year|298|
|At 31 March 2022|2,659|
|Net book values:||
|At 31 March 2021|1,486|
|At 31 March 2022|1,188|





## 

## 

## 

|7.|Debtors|for the year ended 31 March 2022|||
|---|---|---|---|---|
||||2022|2021|
||Grant debtors||84,617|13,850|
||Other debtors||38,119|4,286|
||P repayments||6,591|5,736|
||||129,327|23,872|
|8.|Creditors: amounts|falling due within one year|2022f|2021<br>E|
||Trade creditors||6,470|2,743|
||Tax and social security||7,439|6,126|
||Accruals<br>&deferred|income|40,482|71,260|
||||54,391|80,129|



||Operating<br>lease com|mitments||||||
|---|---|---|---|---|---|---|---|
||Total future minimum|lease payments|under|non-cancellable|operating<br>leases were:|||
|||||||2022||
||Land and buildings:|||||||
||Operating<br>leases which expire|||||||
||- within one year|||||10,800||
||- in second to fifth|years inclusive||||16,200||
|10.|Analysis of net assets between funds|||||||
|||||Unrestricted||Restricted|2022|
||||||Funds<br>E|Funds<br>E|Totalf|
||Tangible fixed assets||||1,188||1,188|
||Current assets||||304,642|25,851|330,493|
||Current<br>liabilities||||(54,391)||(54,391)|
||Net assets at 31 March 2022||||251,439|25,851|277,290|
|||||Unrestricted||Restricted|2021|
||||||Funds|Funds|Total|
||||||F|E|K|
||Tangible fixed assets||||1,486||1,486|
||Current assets||||251,845|16,885|268,730|
||Current<br>liabilities||||(80,129)||(80,129)|
||Net assets at 31 March 2021||||173,202|16,885|190,087|





## 

## 

|Movement<br>in funds|||||||||
|---|---|---|---|---|---|---|---|---|
|2022|||Opening|||||Closing|
||||balancef|Income<br>E||Expenditure|Transfer<br>E|balance|
|Restricted funds:|||||||||
|Group Support<br>IDVA Court Service<br>Website costs and development|||8,875<br>{253)<br>7,463|14,612<br>41,212||(23,437)<br>{32,554)<br>(7,784)|321|50<br>8,405|
|Translation|||800|||(75)||725|
|Diversity and Inclusion<br>Chief Executive<br>Service user||Lead||18,500<br>25,618<br>350|'|(17,962)<br>(9,485)<br>(1,302)|952|538<br>16,133|
||||16,885|100,292||(92,599)|1,273|25,851|
|Unrestricted<br>Funds:|||||||||
|Designated<br>IDVA Fund<br>Designated<br>Training<br>Fund|||79,676<br>93,526|230,461<br>136,231||(193,036)<br>(94,146)|(1,273)<br>-|115,828<br>135,611|
||||173,202|366,692||(287,182)|(1,273)|251,439|
|Total Funds|||190,087|466,984||(379,781)||277,290|
|2021|||Opening|||||Closing|
||||balance|Income|Expenditure||Transfer|balance|
||||F|F||F|||
|Restricted funds:|||||||||
|Group Support<br>IDVA Court Service<br>Associate Trainers|||682<br>19,600|10,008<br>1,213<br>13,400||(1,815)<br>(21,066)<br>(13,862)|462|8,875<br>(253)|
|MODUS Software Enhancement<br>Website costs and development|||9,000<br>2,000|19,667||(9,000)<br>(14,204)||7,463|
|COVID expenditure||||2,562||(2,886)|324||
|Translation||||800||||800|
||||31,282|47,650||(62,833)|786|16,885|
|Unrestricted<br>Funds:|||||||||
|Designated<br>IDVA Fund<br>Designated<br>Training<br>Fund|||59,937<br>59,133|183,607<br>168,663||(163,544)<br>(133,808)|(324)<br>(462)|79,676<br>93,526|
||||119,070|352,270||(297,352)|(786)|173,202|
|Total Funds|||150,352|399,920||(360,185)||190,087|





## 

## 

## 

## 

